previous compound ID: 2500 next compound
InChIKey: WREGKURFCTUGRC-POYBYMJQSA-N
SMILES: C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "J Liao" "DY Thomas" "D Rotin" "GW Carlile" "J Goepp" "B Kus" "E Matthes" "JW Hanrahan" "R Robert"

chemical graph of compound 2500





CID is 24066
synonyms found at PubChem are:
zalcitabine, Dideoxycytidine, 2',3'-DIDEOXYCYTIDINE, 7481-89-2, ddCyd, HIVID, ddC, Cytidine, 2',3'-dideoxy-, Zalcitibine, 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, ddC (Antiviral), 2,3-dideoxycytidine, NSC 606170, UNII-6L3XT8CB3I, Ro 24-2027/000, CCRIS 692, Hivid(TM), Zalcitabine [USAN:INN:BAN], Hivid (TN), Interferon AD + ddC, C9H13N3O3, HSDB 7156, ddC & sCD4, Ro-24-2027/000, ddC & GM-CSF, PC-SOD & ddC, 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine, CHEMBL853, BRN 0654956, 6L3XT8CB3I, Zalcitabine (JAN/USP/INN), DS-4152 & ddC, CHEBI:10101, WREGKURFCTUGRC-POYBYMJQSA-N, ddC & NP (from PHCA or HSA), SRI-7707, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one, 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE, BETA-D-2',3'-DIDEOXYCYTIDINE, KS-1130, NCGC00090705-08, DSSTox_CID_3747, D 5782, DSSTox_RID_77182, DSSTox_GSID_23747, 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine, 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein), 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine, Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine, NSC606170, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, NSC-606170, 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate), SMR000058253, 3-[(5S,2R)-5-(hydroxymethyl)oxolan-2-yl]-6-amino-3-hydropyrimidin-2-one, Zalcitabine [USAN:USP:INN:BAN], CAS-7481-89-2, Beta-D-DDC, DdC & IFN-alpha, ddC & IFN.alpha., .beta.-D-DDC, dideoxycytidine (DDC), DdC & Interferon alpha, Prestwick0_001037, Prestwick1_001037, Prestwick2_001037, Prestwick3_001037, ddC & Interferon.alpha., 2', 3'-dideoxycytidine, bmse000712, D0DC7N, D0M1YO, D0Z9QR, DDC (DDC), UPCMLD-DP115, AC1L2N6R, SCHEMBL3598, TimTec1_004969, Lopac0_000360, BSPBio_001253, 5-25-14-00313 (Beilstein Handbook Reference), MLS000069636, MLS000759540, MLS001055363, MLS001424210, MLS006011951, 2',3-DIDEOXYCYTIDINE, SPBio_003104, BPBio1_001378, GTPL4828, ddC|||2',3'-Dideoxycytidine, DTXSID0023747, UPCMLD-DP115:001, KS-00000MRJ, ZINC39906, AOB5609, MolPort-002-885-873, MolPort-003-699-779, HMS1548B19, HMS1571O15, HMS2051H18, HMS2090C12, HMS2098O15, HMS2236N08, HMS3261G21, HMS3715O15, Pharmakon1600-01502360, .beta.-D-2',3'-Dideoxycytidine, Zalcitabine, 2'3'-Dideoxycytidine, BCP13878, Hivid;Dideoxycytidine;NSC 606170, Tox21_113491, Tox21_201655, Tox21_303169, Tox21_500360, AC-824, ANW-36530, BDBM50145605, MFCD00012188, NSC759655, s1719, SBB066036, AKOS015854844, AKOS015894505, Tox21_113491_1, AB01085, CCG-101050, CS-1110, DB00943, LP00360, LS-1645, MCULE-6071296177, NC00300, NSC-759655, RTC-064018, SRI-7707-13, SRI-7707-14, SRI-7707_15, SRI-7707_17, NCGC00090705-01, NCGC00090705-02, NCGC00090705-03, NCGC00090705-05, NCGC00090705-06, NCGC00090705-07, NCGC00090705-09, NCGC00090705-10, NCGC00090705-11, NCGC00090705-13, NCGC00090705-15, NCGC00179242-01, NCGC00257202-01, NCGC00259204-01, NCGC00261045-01, AJ-08916, AN-15472, BC203863, CPD000058253, HY-17392, K278, SAM001246779, SC-09165, ST069364, ZB001188, 2',3'-Dideoxycytidine & Interferon-alpha, 2',3'-Dideoxycytidine & Interferon.alpha., 2',3'-Dideoxycytidine, >=98% (HPLC), AB0014137, AB2000246, DB-019728, Ro-242027000, TC-064018, D3581, EU-0100360, Ro-24-2027000, ST24043185, Cytidine, 2',3'-dideoxy & Interferon alpha, 2',3'-Dideoxycytidine, >=99.0% (HPLC), C07207, D00412, M-2084, 42060-EP2295503A1, 42060-EP2298761A1, 42060-EP2305695A2, 42060-EP2305696A2, 42060-EP2305697A2, 42060-EP2305698A2, 42060-EP2311808A1, 42060-EP2311829A1, 78798-EP2298783A1, 78798-EP2305695A2, 78798-EP2305696A2, 78798-EP2305697A2, 78798-EP2305698A2, Cytidine, 2',3'-dideoxy- & Interferon.alpha., 481D892, Hivid, Dideoxycytidine, NSC 606170, Zalcitabine, SR-01000075822, SR-01000736919, J-700276, Q-201941, SR-01000075822-1, SR-01000736919-5, 1-(2',3'-DIDEOXY-BETA-RIBOFURANOSYL)CYTOSINE, Cytidine, 2',3'-dideoxy- & Colony-stimulating factor, Cytidine, 2',3'-dideoxy-& Colony-stimulating factor, Ro-242027000/Ro-24-2027-000, Z1550648753, Zalcitabine, United States Pharmacopeia (USP) Reference Standard, 4-Amino-1-(5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one, .beta.-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor, 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)TETRAHYDRO-2-FURANYL]-2(1H)-PYRIMIDINONE, Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor